PubRank

J Y Djeu

Author PubWeight™ 132.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 1979 2.80
2 Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 1983 2.67
3 Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer 1977 2.39
4 Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol 1986 2.37
5 Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol 2000 2.35
6 Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 1985 2.33
7 Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest 1983 2.32
8 Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol 1983 1.84
9 Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med 1982 1.81
10 Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 1999 1.80
11 Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol 1988 1.73
12 Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol 1986 1.62
13 High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood 1993 1.54
14 Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon. J Immunol 1979 1.49
15 Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2. J Exp Med 1998 1.48
16 Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 1985 1.43
17 Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene 2006 1.40
18 Immune-type receptor genes in zebrafish share genetic and functional properties with genes encoded by the mammalian leukocyte receptor cluster. Proc Natl Acad Sci U S A 2001 1.40
19 Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 1984 1.38
20 Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem 1992 1.35
21 IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology 1993 1.35
22 Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 2001 1.32
23 Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol 1989 1.30
24 Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J Exp Med 1980 1.23
25 Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator. J Immunol 1986 1.23
26 Chronic neutropenia mediated by fas ligand. Blood 2000 1.20
27 Human large granular lymphocytes are potent producers of interleukin-1. Nature 1984 1.18
28 Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol 1989 1.17
29 Transformation of owl monkey T cells in vitro with Herpesvirus saimiri. Proc Natl Acad Sci U S A 1984 1.14
30 Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol 1987 1.14
31 Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood 1991 1.13
32 Identification of a mannoprotein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. J Infect Dis 1992 1.13
33 Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 1985 1.13
34 Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun 1988 1.12
35 IFN-gamma enhances sensitivity of human macrophages to extracellular ATP-mediated lysis. J Immunol 1991 1.12
36 Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 1986 1.11
37 Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J Immunol 2000 1.10
38 Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem Pharmacol 1991 1.09
39 A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods 1986 1.08
40 Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. Infect Immun 1991 1.07
41 Inhibition of rat mixed lymphocyte cultures by suppressor macrophages. Cell Immunol 1977 1.07
42 Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol 1996 1.07
43 Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages. J Infect Dis 1991 1.06
44 Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes. J Clin Invest 1985 1.04
45 Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 1995 1.04
46 Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans. Infect Immun 1992 1.04
47 Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood 1991 1.02
48 Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol 1985 1.01
49 Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering. J Immunol 1986 1.01
50 IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 1994 1.01
51 Stimulation of guanylate cyclase activity and reduction of adenylate cyclase activity by granulocyte-macrophage colony-stimulating factor in human blood neutrophils. J Immunol 1988 1.00
52 Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood 1994 1.00
53 Induction of tumor necrosis factor by Legionella pneumophila. Infect Immun 1987 1.00
54 Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 1994 0.99
55 Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol 1982 0.99
56 Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma. J Natl Cancer Inst 1976 0.98
57 Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Cancer Treat Rep 1978 0.96
58 Differential release of interleukin (IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 1992 0.96
59 Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol 1979 0.96
60 Inhibition of extracellular ATP-mediated lysis of human macrophages by calmodulin antagonists. J Cell Biochem 1995 0.94
61 Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood 1985 0.94
62 Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1. Cell Immunol 1989 0.93
63 Restoration of lytic function in a human natural killer cell line by gene transfection. Cell Immunol 1994 0.93
64 Candida albicans expresses a fibronectin receptor antigenically related to alpha 5 beta 1 integrin. Microbiology 1994 0.93
65 Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes. J Immunol 1983 0.92
66 Cellular microcytotoxicity in human tumor systems: analysis of results. J Natl Cancer Inst 1975 0.91
67 Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol Immunother 1985 0.91
68 A rapid [3H]glycerol radioassay for determination of monocyte-mediated growth inhibition of Mycobacterium avium. J Immunol Methods 1990 0.91
69 Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 1995 0.90
70 Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. Cancer Res 1996 0.90
71 Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas. J Immunol 1990 0.90
72 Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microbiol 1993 0.90
73 Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. Ann N Y Acad Sci 1980 0.89
74 Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta. J Immunol 1993 0.89
75 The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C. Immunopharmacology 1979 0.89
76 Functional association of TGF-beta receptor II with cyclin B. Oncogene 1999 0.86
77 Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF. J Immunol 1988 0.86
78 Lymphocytes forming rosettes with sheep erythrocytes in metastatic pleural effusions. J Natl Cancer Inst 1976 0.86
79 Decreased interleukin 2 inhibitor in sera of patients with autoimmune disorders. Clin Exp Immunol 1986 0.86
80 Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression. Infect Immun 1992 0.85
81 Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J Immunol 1994 0.85
82 Selective growth of natural cytotoxic but not natural killer effector cells in interleukin-3. Nature 1984 0.85
83 Large granular lymphocytes provide an accessory function in the in vitro development of influenza A virus-specific cytotoxic T cells. J Immunol 1984 0.84
84 IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils. Immunobiology 2000 0.83
85 Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1985 0.83
86 Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus. Clin Immunol Immunopathol 1982 0.83
87 Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. Cell Immunol 1981 0.82
88 Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: comparison with other LAK targets. Int J Cancer 1990 0.82
89 Expression of interleukin-2 receptor gamma chain on human neutrophils. Blood 1994 0.82
90 Differential modulation of surface antigens on human macrophages by IFN-gamma and GM-CSF: effect on susceptibility to LAK lysis. J Leukoc Biol 1991 0.82
91 Retinoblastoma protein activation of interleukin 8 expression inhibits tumor cell survival in nude mice. Cell Growth Differ 2000 0.81
92 Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer. Anticancer Res 1994 0.80
93 An alpha 5 beta 1-like integrin receptor mediates the binding of less pathogenic Candida species to fibronectin. J Med Microbiol 1995 0.80
94 Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. Cell Growth Differ 1999 0.80
95 Direct killing of interleukin-2-transfected tumor cells by human neutrophils. Int J Cancer 1996 0.79
96 Calcium-dependent natural killer and calcium-independent natural cytotoxic activities in an IL-2-dependent killer cell line. J Immunol 1990 0.79
97 Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta. Blood 1993 0.79
98 Effect of the psychoactive metabolite of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol 1994 0.79
99 Secretion of a suppressor cell inducing factor by an interleukin-3 dependent cell line with natural cytotoxic activity. Cell Immunol 1986 0.79
100 Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells. J Immunol 1991 0.78
101 Enhancement of human allogeneic cytotoxic responses by interferons. J Immunopharmacol 1985 0.78
102 Lymphokine-activated killer cell regulation of T-cell-mediated immunity to Candida albicans. Infect Immun 1992 0.78
103 Suppression by cannabinoids of a cloned cell line with natural killer cell activity. Proc Soc Exp Biol Med 1988 0.78
104 Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor. Cancer Res 1989 0.78
105 Interleukin 2 therapy in infectious diseases: rationale and prospects. Infection 1984 0.78
106 Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus. J Immunol 1979 0.77
107 Interferon and natural killer (NK) cells. Tex Rep Biol Med 1983 0.77
108 Involvement of HLA-DR+ large granular lymphocytes in the induction of tumor necrosis factor by Mycobacterium avium-intracellulare complex. J Leukoc Biol 1991 0.77
109 Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients. Cancer Res 1988 0.77
110 Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma. J Immunol 1988 0.77
111 Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats. Cell Immunol 1976 0.77
112 The effect of specific anti-rat thymocyte serum on cell-mediated tumor immunity and other lymphocyte functions. Cell Immunol 1974 0.77
113 Suppression by delta-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Int J Immunopharmacol 1988 0.76
114 Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1996 0.76
115 Candida antigen titre dilution and death after injury. Br J Surg 1997 0.76
116 Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon. J Infect Dis 1985 0.76
117 Expression of interleukin-2 receptor gamma on human monocytes: characterization of lineage specific post-translational modifications. Eur J Immunol 1995 0.76
118 Selective inhibition of natural killer but not natural cytotoxic activity in a cloned cell line by delta-9-tetrahydrocannabinol. J Leukoc Biol 1991 0.76
119 Impaired polymorphonuclear leukocyte anticandidal function in injured adults with elevated Candida antigen titers. Arch Surg 1993 0.76
120 Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine. Transplant Proc 1984 0.76
121 Interleukin-12-mediated tumoricidal activity of patient lymphocytes in an autologous in vitro ovarian cancer assay system. Gynecol Oncol 1995 0.76
122 Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. J Soc Gynecol Investig 1998 0.76
123 Lysis of human monocytic leukemia cells by extracellular adenosine triphosphate: mechanism and characterization of the adenosine triphosphate receptor. Blood 1993 0.75
124 Elevated Candida antigen titers are associated with neutrophil dysfunction after injury. Clin Diagn Lab Immunol 1994 0.75
125 Intact autocrine activation and cytokine production by PMNs from injured adults with elevated Candida antigen titres. Injury 1998 0.75
126 Interleukin 2 therapy in infectious diseases: rationale and prospects. Infection 1985 0.75
127 Monocytes overcome lymphocyte dysfunction in injured adults with elevated Candida antigen titers. J Trauma 1994 0.75
128 Recombinant interleukin-8 induces changes in cytosolic Ca2+ in human neutrophils. J Infect Dis 1992 0.75
129 Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor. Nat Immun Cell Growth Regul 1989 0.75
130 Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon. J Am Vet Med Assoc 1982 0.75
131 Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin. J Immunol 1976 0.75
132 CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cells. J Leukoc Biol 1997 0.75
133 Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24. J Urol 1977 0.75
134 Lymphocyte dysfunction in injured adults with elevated Candida antigen titers. Surgery 1993 0.75
135 Augmentation of carcinoembryonic antigen release from intact, viable tumor cells by a factor in human serum. Ann Surg Oncol 1995 0.75
136 Secretion of a suppressor cell inducing factor by an interleukin 3-dependent cell line with natural cytotoxic activity. III. Comparison with other interleukin 3-dependent cell lines. Cell Immunol 1988 0.75
137 Effect of lymphokines on 35sulfate uptake by the glomerular basement membrane. Nephron 1995 0.75
138 Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24. Surg Forum 1975 0.75
139 Phospholipase C-gamma 1 is present on the surface of human colorectal cancer cells. Biochem Biophys Res Commun 1994 0.75
140 Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay. J Infect 1996 0.75
141 Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction. Cancer Res 1974 0.75
142 An alternative medium supplement for the culturing and growth of human peritoneal mesothelial cells. In Vitro Cell Dev Biol Anim 1996 0.75
143 Candida antigen titer is a marker of neutrophil dysfunction after severe injury. J Trauma 1994 0.75
144 Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients. Transplantation 1984 0.75
145 Serum soluble interleukin-2 receptor alpha levels in patients with gynecologic cancers: early effect of surgery. Am J Reprod Immunol 1994 0.75